Interpretation/Evaluation of Laboratory Data CLS 552 Human Microbiology & Immunology Laboratory Note: View this PowerPoint as a ‘Full Screen Slide Show’.

Slides:



Advertisements
Similar presentations
DAVID R. WOODARD MSC, CIC, CPHQ, CLS Hospital Ecology.
Advertisements

Massachusetts Department of Public Health
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
CRE Surveillance Activities
Community-acquired bacterial infections. The most frequent etiologic agents of bacterial tonsillitis and tonsillopharyngitis are Streptococcus pyogenes.
WHONET Part II Expert System Dr.T.V.Rao MD 1. Isolate alerts WHONET now permits the user to take advantage of pre-defined or user-defined expert rules.
Antimicrobial Susceptibility Testing – Part II
Lecture 3 Antimicrobials and Susceptibility tests Dr. Abdelraouf A. Elmanama Islamic University-Gaza Medical Technology Department.
Screening for new antibiotics
Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.
Antimicrobial Susceptibility Testing (AST)
PHT 381 Lab # 8. MIC: MIC: It is the lowest concentration of the antimicrobial agent that inhibits the growth of the test organism but not necessarily.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
Methods Revised Abstract Methods Results TP-271 is a Potent, Broad-Spectrum Fluorocycline with Activity Against Community-Acquired Bacterial Respiratory.
Microbiology Antimicrobial Susceptibility Testing – Part I Karen Honeycutt, M.Ed., MT(ASCP)SM CLS 418 Clinical Microbiology Student Laboratory Session.
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
Do Physicians Find Our AST Reports As Confusing As We Do? Louis B. Rice, M.D. Louis Stokes Cleveland VA Medical Center and Case Western Reserve University.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Feb 2007 Dr W Lowman THE BASICS OF CLINICAL RELEVANCE.
University of Tabuk Faculty of Applied Medical Science
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training.
KIRBY – BAUER MINIMUM INHIBITORY CONCENTRATION MINIMUM BACTERIOCIDAL CONCENTRATION.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
김의종(집필대표), 강정옥, 김미나, 김민중, 김성일, 이경원, 이도현, 이장호, 이남용, 이창규, 신종희, 장철훈, 최혜심
Lab 13 Microbial Control with Chemical Agents. Staphylococcus aureus Escherichia coli Do all disinfectants and antiseptics work equally well against.
ANALYTICAL PROCESS CONTROL
Methods for detecting resistance Goal: To determine whether organism expresses resistances to agents potentially used for therapy Designed to determine.
Points for Discussion Anti-Infective Drugs Advisory Committee Meeting March 5, 2003.
Supplemental testing methods
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
Susceptibility (Sensitivity) Testing: Results Pharmaceutical Microbiology – Practical Course Semester One_ Sensitivity Results & MIC Broth Dilution/
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.
Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.
Antibiotics Basmah almaarik
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
Lab: 6 ANTIBIOTIC SENSITIVITY TESTING
"Don't forget to take a handful of our complimentary antibiotics on your way out“
Lab # 1. Antimicrobial Therapy  Natural antibiotic agents:  Produced by microorganisms:  Penicillium notatum – penicillin  Semi-synthetic antibiotic.
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Antimicrobial Susceptibility Testing (AST)
The Role of the Microbiology Laboratory in AMS programs
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Chapter 1: Introduction to Multidrug – Resistant Organisms
Antibiotic Susceptibility Testing
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Antibiogram By:Dr. S. S. Khoramrooz In the name of God
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli  R.A. Hickman, D. Hughes,
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
…monitoring trends in antimicrobial resistance in Canada
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Antibiotic susceptibility testing
Jacques Sirot, Patrice Courvalin, Claude-James Soussy 
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
…monitoring trends in antimicrobial resistance in Canada
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
Presentation transcript:

Interpretation/Evaluation of Laboratory Data CLS 552 Human Microbiology & Immunology Laboratory Note: View this PowerPoint as a ‘Full Screen Slide Show’. In the right hand corner of the screen, click on the ‘Full Screen Slide Show’ icon. To advance, perform left-mouse click.

MIC Interpretation MIC = minimum antibiotic concentration tested that visibly inhibits growth First determine if sterility and growth controls have appropriate results Growth Control = Growth Sterility Control = No growth MIC wells are compared to the above quality control wells

MIC Interpretation – Escherichia coli 4.0 micrograms/ml > 64.0 micrograms/ml MIC must be greater than 64.0 micrograms/ml or the highest concentration tested MIC = < 4.0 micrograms/ml MIC could = 4.0, but could also be at a much lower dilution

MIC Interpretation – Escherichia coli Gentamicin = 4.0 micrograms/ml Ampicillin = > 64.0 micrograms/ml Imipenem = < 4.0 micrograms/ml After MICs have been determined, the next step is to determine if the values indicate the organism tested is susceptible (S), intermediate (I) or resistant (R) to a particular antibiotic S, I or R status is determined by using universal, published standardized criteria

MIC Interpretation – Escherichia coli Standardized Interpretation Criteria Select the appropriate Minimum Inhibitory Concentration (MIC) Interpretive Standards to use Category examples: – Staphylococcus sp. – Enterococcus sp. – Streptococcus pneumoniae – Streptococcus sp. other than Streptococcus pneumoniae – Enterobacteriaceae (e.g. Escherichia coli) – Pseudomonas aeruginosa and Other Non- Enterobacteriaceae

MIC Interpretation – Escherichia coli Standardized Interpretation Criteria E. coli = Enterobacteriaceae (gram-negative rod) Previously determined: Ampicillin MIC = >64 micrograms/ml Previously determined: Ampicillin MIC = >64 micrograms/ml = Resistant (R)

MIC Interpretation – Escherichia coli Standardized Interpretation Criteria E. coli = Enterobacteriaceae (gram-negative rod) Previously determined: Imipenem MIC = < 4.0 micrograms/ml Gentamicin = 4.0 micrograms /ml Previously determined: Imipenem MIC = < 4.0 micrograms/ml = Susceptible (S) Gentamicin = 4.0 micrograms /ml Previously determined: Imipenem MIC = < 4.0 micrograms/ml = Susceptible (S) Gentamicin = 4.0 micrograms /ml = Susceptible (S)

MIC Data Evaluation – E. coli isolate Gentamicin = 4.0 micrograms/ml = S Ampicillin = > 64.0 micrograms/ml = R Imipenem = < 4.0 micrograms/ml = S The next step: evaluate the MIC data with cumulative antibiogram data Clinical microbiology laboratories usually publish susceptibility data at six month or year intervals

Cumulative Antibiogram Data Reported as the % susceptible for a defined period Total isolate number tested of a particular organism for the defined period listed

MIC Data Evaluation – E. coli isolate Isolate tested: Imipenem = <4.0 micrograms/ml = S Antibiogram data = 99% of E. coli isolates tested were susceptible  1% were not susceptible Therefore, this isolate does follow predictable patterns of susceptibility. Based upon the cumulative antibiogram, we would expect E. coli to be (S).

MIC Data Evaluation – E. coli isolate Isolate tested: Gentamicin = 4.0 micrograms/ml = S Antibiogram data = 93% of E. coli isolates tested were susceptible  7% were not susceptible Therefore, this isolate does follow predictable patterns of susceptibility. Based upon the cumulative antibiogram, we would expect E. coli to be (S).

MIC Data Evaluation – E. coli isolate Isolate tested: Ampicillin = > 64.0 micrograms/ml = R Antibiogram data = 53% of E. coli isolates tested were susceptible  47% were not susceptible Therefore, no predictive value prior to susceptibility data

Predictable Patterns of Susceptibility There are also general predictable patterns of susceptibility. See Unit 3, pg. 5 (orange color) Read as if, then statements For example, item 7: If isolate is Klebsiella pneumoniae or Citrobacter koseri, then should be (R) to ampicillin

Overview 1.Interpret the MIC values of the susceptibility test 2.Determine if the MIC values are S, I or R for each antibiotic tested using published standardized criteria charts 3.Evaluate the data by comparing to the: Cumulative antibiogram Known predictable patterns of susceptibility pg. 5, Unit 3